Mankind Pharma and Innovent Biologics Partner to Launch Groundbreaking PD-1 Immunotherapy in India

Duchenne Muscular Dystrophy: Diagnosis, Treatment, and Emerging Therapies

Ikena Oncology and Inmagene Biopharmaceuticals Announce Merger to Form ImageneBio

Fujirebio and Eisai Partner to Advance Diagnostics for Neurodegenerative Diseases

European Commission Approves Opdivo® Plus Yervoy® for First-Line Treatment of MSI-H or dMMR mCRC

Deerfield Management to Acquire Singular Genomics for $20 Per Share in All-Cash Deal

EU Approval of Tagrisso Sets New Standard for EGFR-Mutated NSCLC Treatment

Aurobindo Pharma’s Subsidiary CuraTeQ Secures UK Approval for Bevacizumab Biosimilar

SCG Cell Therapy Partners with A*STAR BTI and NATi to Advance RNA-Based Therapeutics

Korea's National Bio Big Data Project: Advancing Precision Medicine with Macrogen and Illumina

GST Exemption Announced for Cancer Treatment Gene Therapy

AIIMS Develops Affordable CAR-T Cell Therapy for Multiple Myeloma

Sangamo Therapeutics and Astellas Collaborate on Innovative Gene Therapy for Neurological Diseases

FDA Clears IND for Arbor Biotechnologies’ ABO-101 Gene Editing Therapeutic for Primary Hyperoxaluria Type 1

Fortis Healthcare Acquires Stake in Agilus Diagnostics

Home
/
update
/
details

RNT Medical College Udaipur to Launch India's First Sickle Cell Wellness Hub

NextEdge Admin

13 Aug 2024

2 min 8 sec

Novo Nordisk Education Foundation (NNEF), a non-profit established by Novo Nordisk India, has partnered with Ravindra Nath Tagore (RNT) Medical College, Udaipur, to create a 'Sickle Cell Wellness Hub' dedicated to individuals with Sickle Cell Disease (SCD). This initiative aligns with India's National Sickle Cell Anemia Elimination Mission 2023, targeting the eradication of SCD by 2047.

The MoU was signed by Dr. Vipin Mathur, Principal of RNT Medical College, and Vikrant Shrotriya, Managing Trustee of NNEF, with key medical professionals in attendance. The Wellness Hub will offer comprehensive care, including diagnosis, treatment, monitoring, dietary guidance, and counseling, particularly benefiting Rajasthan's tribal communities, who are disproportionately affected by SCD. Approximately 1 in 86 births among India's Scheduled Tribes (ST) communities are impacted by this genetic disorder.

The partnership aims to enhance existing SCD care infrastructure, making it more child-friendly and strengthening capacity-building among healthcare providers. Educational and awareness programs will also be conducted for caregivers and frontline health workers.

Dr. Lakhan Poswal, Nodal Officer of the SCD Center of Excellence at RNT Medical College, emphasized the significance of this collaboration in addressing SCD's burden in Rajasthan. The initiative seeks to promote early screening and provide robust healthcare infrastructure, improving the quality of life for those affected by SCD through education, awareness, and access to advanced care.